Skip to main content
Cynthia Sirard, MD, Oncology, Cambridge, MA

CynthiaASirardMD

Oncology Cambridge, MA

Physician

Dr. Sirard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sirard's full profile

Already have an account?

  • Office

    500 Kendall St
    # Genzyme
    Cambridge, MA 02142
    Phone+1 617-768-6337

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1996 - 1999
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1996

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1998 - 2025

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Correlation of radiomics of metastatic lesions in gastroesophageal adenocarcinoma (GEA) with tumoral DKK1 mRNA expression and other immune biomarkers in patients (pts)... 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020

Press Mentions

  • Leap Therapeutics to Present Updated Data from Part a of the DisTinGuish Study of DKN-01 plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting
    Leap Therapeutics to Present Updated Data from Part a of the DisTinGuish Study of DKN-01 plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual MeetingMay 25th, 2023
  • Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 plus Tislelizumab at the ESMO 2021 Congress
    Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 plus Tislelizumab at the ESMO 2021 CongressSeptember 13th, 2021
  • Charles Bancroft Makes Quick Leap from Bristol Myers Exec Team to GSK; Medicxi Adds Two New Partners to Its Team
    Charles Bancroft Makes Quick Leap from Bristol Myers Exec Team to GSK; Medicxi Adds Two New Partners to Its TeamMarch 20th, 2020
  • Join now to see all

Professional Memberships